Coya Therapeutics annual operating margin
2023
2024
2025
Coya Therapeutics Operating Margin Growth & History (COYA)
Coya Therapeutics's operating margin was −283.87% for fiscal 2025.
View full Coya Therapeutics company overviewCoya Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −283.87% | +201.49 pp |
| 2024 | 2024-12-31 | −485.35% | −353.68 pp |
| 2023 | 2023-12-31 | −131.67% | — |
Coya Therapeutics quarterly operating margin
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −2,891.13% | +1029.34 pp |
| Q1 2026 | 2026-03-31 | −3,042.13% | −65.24 pp |
| Q4 2025 | 2025-12-31 | −152.30% | +208879.21 pp |
| Q3 2025 | 2025-09-30 | −68.26% | — |
| Q2 2025 | 2025-06-30 | −3,920.47% | −3825.99 pp |
| Q1 2025 | 2025-03-31 | −2,976.89% | +1345.95 pp |
| Q4 2024 | 2024-12-31 | −209,031.51% | −209061.75 pp |
| Q2 2024 | 2024-06-30 | −94.48% | — |
| Q1 2024 | 2024-03-31 | −4,322.84% | — |
| Q4 2023 | 2023-12-31 | 30.24% | — |
Coya Therapeutics operating margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Coya Therapeutics's operating margin decreased from −131.67% to −283.87%, a change of −152.19 percentage points. The latest reported quarter, Q2 2026, shows −2,891.13%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Coya Therapeutics source filings ↗